alanyl-glycyl-glycine has been researched along with Ovarian Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, JY; Jia, LZ; Ren, XC; Wang, N; Wang, SJ; Zhang, JM; Zhao, XM | 1 |
1 other study(ies) available for alanyl-glycyl-glycine and Ovarian Neoplasms
| Article | Year |
|---|---|
Evaluation of 99mTc-peptide-ZHER2:342 Affibody® molecule for in vivo molecular imaging.
Topics: Animals; Cell Line, Tumor; Feasibility Studies; Female; Humans; Mice, Nude; Molecular Imaging; Oligopeptides; Ovarian Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Random Allocation; Receptor, ErbB-2; Recombinant Fusion Proteins; Technetium; Tissue Distribution; Tumor Cells, Cultured | 2014 |